SCHEDULE 13G/A: BlackRock, Inc. Discloses Continued 8.1% Passive Stake in Albemarle Corporation

BlackRock, Inc. has filed an amended Schedule 13G, confirming its beneficial ownership of 8.1% of Albemarle Corporation's common stock as of March 31, 2025.

Summary

• BlackRock, Inc. filed Amendment No. 16 to its Schedule 13G regarding its beneficial ownership in Albemarle Corporation.
• As of March 31, 2025, BlackRock, Inc. beneficially owns an aggregate of 9,694,388 shares of Albemarle Corporation's common stock.
• This ownership represents 8.1% of the total outstanding common stock of Albemarle Corporation.
• BlackRock, Inc. holds sole voting power over 8,970,063 shares and sole dispositive power over 9,694,388 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Albemarle Corporation.
• The filing also includes an updated Power of Attorney, effective January 21, 2025, authorizing specific individuals to execute SEC filings on BlackRock's behalf.

Sentiment

Score: 7

Explanation: The filing is a routine disclosure of a significant, passive institutional ownership. It indicates continued confidence from a major investor without suggesting any negative or positive operational changes for the company itself. The 'ordinary course of business' statement is neutral to positive.

Positives

• BlackRock, a prominent institutional investor, maintains a significant 8.1% stake in Albemarle, indicating continued confidence in the company.
• The filing explicitly states that the shares are held in the ordinary course of business and not for the purpose of influencing control, suggesting a stable, passive investment.

Risks

• The document does not disclose any specific operational or financial risks related to Albemarle Corporation, as it is a beneficial ownership report. The only 'risk' context is the certification that BlackRock is not seeking to influence control, which mitigates potential activist investor concerns.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding Albemarle Corporation's future performance or BlackRock's future investment intentions beyond the scope of this passive holding.

Management Comments

• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."

Industry Context

Albemarle Corporation is a leading global producer of lithium, bromine, and catalysts, critical materials for electric vehicle batteries, flame retardants, and refining. BlackRock's significant passive stake reflects its investment in a key player within the growing clean energy and specialty chemicals sectors, aligning with broader market trends towards sustainable technologies.

Comparison to Industry Standards

• This Schedule 13G filing is a standard regulatory disclosure for institutional investors holding more than 5% of a company's stock, consistent with SEC requirements.
• BlackRock's 8.1% stake in Albemarle is a substantial passive investment, typical for large asset managers like BlackRock across various industries and comparable to similar institutional holdings in other major chemical or materials companies.
• No specific comparable companies, projects, or results are detailed within this filing, as its scope is limited to BlackRock's beneficial ownership disclosure.

Corporate Governance

Stakeholder Impact

• Shareholders: Provides transparency regarding a major institutional investor's continued significant stake, which may reinforce confidence in the company's long-term prospects.
• Management: Awareness of a substantial passive shareholder, but no direct impact on operational or strategic decisions as the holding is not for control purposes.

Next Steps

• BlackRock, Inc. will continue to file amendments to Schedule 13G as required by SEC regulations if its beneficial ownership percentage in Albemarle Corporation changes significantly.

Key Dates

Keywords

Albemarle Corporation, BlackRock Inc., Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Lithium, Specialty Chemicals